Antistax® in Patients With Chronic Venous Insufficiency
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to determine the efficacy and tolerability of two dose levels of Antistax relative to
placebo in patients suffering from CVI grade I or incipient grade II